Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer
Increasing evidence indicates that 2-hydroxyglutarate (2HG) is an oncometabolite that drives tumour formation and progression. Due to mutations in isocitrate dehydrogenase (IDH) and the dysregulation of other enzymes, 2HG accumulates significantly in tumour cells. Due to its structural similarity to...
Saved in:
Main Authors: | Jie Hao (Author), Ziyi Huang (Author), Siyue Zhang (Author), Kefan Song (Author), Juncheng Wang (Author), Chao Gao (Author), Zhiqing Fang (Author), Ning Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyglutaric Acidemia
by: J Gordon Millichap
Published: (1992) -
Autism and Hydroxyglutaric Aciduria
by: J Gordon Millichap
Published: (2008) -
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
by: Garrett Brinkley, et al.
Published: (2020) -
Clinical, Neuroimaging, and Genetic Features of the Patients with L-2-Hydroxyglutaric Aciduria
by: Ebru Canda, et al.
Published: (2018) -
Two novel L2HGDH mutations identified in a rare Chinese family with L-2-hydroxyglutaric aciduria
by: Wei Peng, et al.
Published: (2018)